Association between vitamin D deficiency and pre-existing resistance-associated hepatitis C virus NS5A variants-Reference-Cited by-同舟云学术

Association between vitamin D deficiency and pre-existing resistance-associated hepatitis C virus NS5A variants

Published:2016-08-26 Issue:7 Volume:47 Page:641-649
ISSN:1386-6346
Container-title:Hepatology Research
language:en
Short-container-title:Hepatol Res

Author:

Okubo Tomomi¹,Atsukawa Masanori¹,Tsubota Akihito²,Shimada Noritomo³,Abe Hiroshi⁴,Yoshizawa Kai⁵,Arai Taeang¹,Nakagawa Ai¹,Itokawa Norio¹,Kondo Chisa¹,Aizawa Yoshio⁴,Iwakiri Katsuhiko⁶

Affiliation:

1. Division of Gastroenterology, Department of Internal Medicine; Nippon Medical School Chiba Hokusoh Hospital; Chiba Japan

2. Core Research Facilities for Basic Science, Research Center for Medical Sciences; Jikei University School of Medicine; Tokyo Japan

3. Division of Gastroenterology and Hepatology; Otakanomori Hospital; Chiba Japan

4. Division of Gastroenterology and Hepatology; Jikei University School of Medicine Katsusika Medical Center; Tokyo Japan

5. Division of Gastroenterology; Machida Municipal Hospital; Tokyo Japan

6. Division of Gastroenterology and Hepatology, Department of Internal Medicine; Nippon Medical School; Tokyo Japan

Publisher

Wiley

Subject

Infectious Diseases,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/hepr.12784/fullpdf

Reference40 articles.

1. World Health Organization Fact sheet no. 164 http://www.who.int/mediacentre/factsheets/fs164/en/

2. Hepatitis C virus infection;Lauer;N Engl J Med,2001

3. Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection;Kumada;Hepatology,2014

4. Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial;Mizokami;Lancet Infect Dis,2015

5. Efficacy and safety of 8 weeks versus 12 weeks of treatment with grazoprevir (MK-5172) and elbasvir (MK-8742) with or without ribavirin in patients with hepatitis C virus genotype 1 mono-infection and HIV/hepatitis C virus co-infection (C-WORTHY): a randomised, open-label phase 2 trial;Sulkowski;Lancet,2015

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chronic Hepatitis C Virus Infection, Extrahepatic Disease and the Impact of New Direct-Acting Antivirals;Pathogens;2024-04-19

2. Vitamin D deficiency in hepatitis C virus infection: what is old? what is new?;European Journal of Gastroenterology & Hepatology;2018-07

3. Efficacy and safety of ledipasvir/sofosbuvir for genotype 1b chronic hepatitis C patients with moderate renal impairment;Hepatology International;2018-03

4. Vitamin D deficiency and hepatitis viruses-associated liver diseases: A literature review;World Journal of Gastroenterology;2018-01-28